Diabetes is one of the leading global health concerns of the 21 st century. Approximately 642 million people with an approximate estimation of 1 in 11 adults, will have diabetes by 2040. Insulin therapy is an integral component in the management of type 2 diabetes. In spite of the established advantages of insulin therapy, there are significant barriers to its use.
Hence, there is a need to understand these barriers and address them. This article provides insight into the current challenges faced while administering insulin and also discusses the possible solution to these challenges. It has been demonstrated that maintaining glycemic control can reduce the risk of microvascular and macrovascular complications associated with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, it is seen that only half of the patients with T2DM reach the recommended A1C…
